A detailed history of Abbrea Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Abbrea Capital, LLC holds 1,820 shares of TMO stock, worth $939,302. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,820
Previous 2,032 10.43%
Holding current value
$939,302
Previous $1.18 Million 14.81%
% of portfolio
0.13%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$541.52 - $599.02 $114,802 - $126,992
-212 Reduced 10.43%
1,820 $1.01 Million
Q1 2024

May 07, 2024

BUY
$528.82 - $599.43 $37,017 - $41,960
70 Added 3.57%
2,032 $1.18 Million
Q4 2023

Feb 02, 2024

SELL
$431.41 - $532.94 $20,276 - $25,048
-47 Reduced 2.34%
1,962 $1.04 Million
Q3 2023

Oct 31, 2023

BUY
$498.29 - $574.41 $31,890 - $36,762
64 Added 3.29%
2,009 $1.02 Million
Q2 2023

Aug 01, 2023

BUY
$508.46 - $591.13 $219,654 - $255,368
432 Added 28.55%
1,945 $1.02 Million
Q1 2023

May 11, 2023

BUY
$535.0 - $604.82 $58,850 - $66,530
110 Added 7.84%
1,513 $873,000
Q4 2022

Feb 08, 2023

SELL
$484.71 - $571.37 $50,894 - $59,993
-105 Reduced 6.96%
1,403 $772,000
Q3 2022

Nov 03, 2022

SELL
$507.19 - $604.49 $102,452 - $122,106
-202 Reduced 11.81%
1,508 $765,000
Q2 2022

Aug 02, 2022

BUY
$500.9 - $612.21 $39,571 - $48,364
79 Added 4.84%
1,710 $930,000
Q1 2022

May 11, 2022

SELL
$524.0 - $644.92 $183,400 - $225,722
-350 Reduced 17.67%
1,631 $964,000
Q4 2021

Feb 04, 2022

BUY
$569.0 - $667.24 $179,804 - $210,847
316 Added 18.98%
1,981 $1.32 Million
Q3 2021

Nov 04, 2021

BUY
$509.53 - $609.78 $282,279 - $337,818
554 Added 49.86%
1,665 $952,000
Q2 2021

Aug 04, 2021

BUY
$441.0 - $508.24 $260,190 - $299,861
590 Added 113.24%
1,111 $561,000
Q1 2021

May 13, 2021

BUY
$439.85 - $518.83 $229,161 - $270,310
521 New
521 $238,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.